A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas

被引:52
作者
Haroon, HA
Buckley, DL
Patankar, TA
Dow, GR
Rutherford, SA
Balériaux, D
Jackson, A
机构
[1] Univ Manchester, Fac Med, Manchester M13 9PT, Lancs, England
[2] Salford Royal Hosp NHS Trust, Hope Hosp, Salford, Lancs, England
[3] Free Univ Brussels, Clin Univ Bruxelles, Hop Erasme, Serv Radiol, Brussels, Belgium
关键词
brain; glioma; dynamic contrast-enhanced MRI; microvascular endothelial permeability; perfusion; blood volume; pharmacokinetic modeling;
D O I
10.1002/jmri.20045
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To compare in a group of patients with cerebral gliomas the estimates of K-trans between a conventionally established pharmacokinetic model and a recently developed first pass method. Materials and Methods: Glioma patients (23) were studied using T-1-weighted dynamic contrast-enhanced magnetic resonance imaging (MRI), and two alternative pharmacokinetic models were used for analysis to derive the volume transfer constant K-trans. These were a modified version of the established model (yielding K-TK) and a recently published method based on first pass leakage profile (FP) of contrast bolus (yielding K-fp). Results: We found a strong correlation between intra-tumoral median K-TK and K-fp (rho = 0.650, P < 0.01), but the values from the conventional model were consistently and significantly higher (mean of inter-tumoral K-fp and K-TK medians were 0.018 minute(-1) and 0.284 minute(-1), respectively, P < 0.001). The spatial distribution of K-TK and K-fp showed poor correlation in the presence of large vascular structures and good correlation elsewhere. Conclusion: K-TK and K-fp produce similar biologic information within voxels not dominated by vascular tissue. The FP method avoids erroneous overestimation of K-trans in areas of significant intravascular contrast. Findings are in keeping with the predictions of previous mathematical simulations.
引用
收藏
页码:527 / 536
页数:10
相关论文
共 25 条
[1]  
Amoroso A, 1997, Eur Rev Med Pharmacol Sci, V1, P17
[2]   VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor [J].
Behzadian, MA ;
Windsor, LJ ;
Ghaly, N ;
Liou, G ;
Tsai, NT ;
Caldwell, RB .
FASEB JOURNAL, 2003, 17 (02) :752-+
[3]   PHARMACOKINETIC PARAMETERS IN CNS GD-DTPA ENHANCED MR IMAGING [J].
BRIX, G ;
SEMMLER, W ;
PORT, R ;
SCHAD, LR ;
LAYER, G ;
LORENZ, WJ .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1991, 15 (04) :621-628
[4]   Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI [J].
Buckley, DL .
MAGNETIC RESONANCE IN MEDICINE, 2002, 47 (03) :601-606
[5]   Role of angiogenesis in tumor growth and metastasis [J].
Folkman, J .
SEMINARS IN ONCOLOGY, 2002, 29 (06) :15-18
[6]   Measurement of the arterial concentration of Gd-DTPA using MRI: A step toward quantitative perfusion imaging [J].
FritzHansen, T ;
Rostrup, E ;
Larsson, HBW ;
Sondergaard, L ;
Ring, P ;
Henriksen, O .
MAGNETIC RESONANCE IN MEDICINE, 1996, 36 (02) :225-231
[7]   Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma [J].
Jackson, A ;
Jayson, GC ;
Li, KL ;
Zhu, XP ;
Checkley, DR ;
Tessier, JJL ;
Waterton, JC .
BRITISH JOURNAL OF RADIOLOGY, 2003, 76 (903) :153-162
[8]   Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model [J].
Jackson, A ;
Haroon, H ;
Zhu, XP ;
Li, KL ;
Thacker, NA ;
Jayson, G .
NMR IN BIOMEDICINE, 2002, 15 (02) :164-173
[9]   Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: Implications for trial design of antiangiogenic antibodies [J].
Jayson, GC ;
Zweit, J ;
Jackson, A ;
Mulatero, C ;
Julyan, P ;
Ranson, M ;
Broughton, L ;
Wagstaff, J ;
Hakannson, L ;
Groenewegen, G ;
Bailey, J ;
Smith, N ;
Hastings, D ;
Lawrance, J ;
Haroon, H ;
Ward, T ;
McGown, AT ;
Tang, M ;
Levitt, D ;
Marreaud, S ;
Lehmann, FF ;
Herold, M ;
Zwierzina, H .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (19) :1484-1493
[10]   QUANTITATION OF BLOOD-BRAIN-BARRIER DEFECT BY MAGNETIC-RESONANCE-IMAGING AND GADOLINIUM-DTPA IN PATIENTS WITH MULTIPLE-SCLEROSIS AND BRAIN-TUMORS [J].
LARSSON, HBW ;
STUBGAARD, M ;
FREDERIKSEN, JL ;
JENSEN, M ;
HENRIKSEN, O ;
PAULSON, OB .
MAGNETIC RESONANCE IN MEDICINE, 1990, 16 (01) :117-131